Digital Diagnostics
Click Therapeutics has begun a clinical trial for its episode migraine digital therapeutic, and Digital Diagnostics is offering its AI-backed diabetic retinopathy screening at select Labcorp locations.
The company will use the funds to expand its platform and accelerate global commercialization.
Formerly known as IDx, the company received FDA De Novo clearance in 2018 for its IDx-DR system used to detect diabetic retinopathy.
Also, a study using autonomous AI to tackle diabetic eye disease will be launched in Bangladesh.
Digital Diagnostics, formerly IDx, is looking to expand into the skin health space with this new purchase.